The Government is close to getting the bill for this $15B fund through parliament.
Around $1.5B is to be allocated to 'medical manufacturing'.
If it gets through and EMV can obtain a significant chunk of funding we may never have to be diluted.
In the public and industry consultation on the proposed Fund, Research Australia has made a detailed submission.
Research Australia is the pre-eminent peak body representing "the entire health and medical research (HMR) pipeline". It's goal is "to unlock the full potential of Australia’s world leading HMR sector to deliver the best health outcomes, and global leadership in health innovation".
It has a highly eminent board including senior execs from CSL, universities and various healthcare businesses
https://researchaustralia.org/annual-report/about/
In its submission to the Government supporting the Fund, Research Australia singled out EMV as an example of a start-up in a sector that should be a key focus of the Fund, as follows:
https://researchaustralia.org/wp-content/uploads/2023/02/RA-NRF-Implementation-Sub-FINAL.pdf
(20min delay)